Related Experiment Videos
What is the optimal blood pressure in patients with diabetes mellitus?
1Department of Internal Medicine, University Hospital, Malmö, Sweden. Peter.Nilsson@medforsk.mas.lu.se
Insights
Treating hypertension is crucial for patients with type 2 diabetes mellitus, as high blood pressure significantly increases cardiovascular risks. Lowering blood pressure, often requiring combination drug therapy, is essential for better patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Hypertension Research
Background:
- Cardiovascular disease (CVD) is the leading cause of mortality in type 2 diabetes mellitus (T2DM) patients.
- Hypertension is a major contributing risk factor for premature mortality from ischemic heart disease and stroke in T2DM.
- Existing clinical guidelines may not recommend sufficiently low blood pressure targets for T2DM patients.
Purpose of the Study:
- To emphasize the critical role of hypertension management in T2DM.
- To advocate for more aggressive blood pressure reduction targets in T2DM patients.
- To highlight the need for combination antihypertensive therapy and drug synergy.
Main Methods:
- Review of recent clinical trials, including the United Kingdom Prospective Diabetes Study (UKPDS) and Hypertension Optimal Treatment (HOT) study.
- Analysis of trends showing benefits of lower diastolic blood pressure levels.
- Discussion of current blood pressure control rates in T2DM populations.
Main Results:
- Clinical trials demonstrate significant benefits from reducing high blood pressure in T2DM.
- Lower diastolic blood pressure levels are associated with increased positive outcomes.
- Current acceptable blood pressure control rates in T2DM are low (e.g., 20-25% in Sweden).
Conclusions:
- Clinicians must intensify hypertension treatment in T2DM patients.
- Achieving tight blood pressure control is paramount for reducing cardiovascular risk.
- Pharmacological synergism through drug combination therapy is necessary for most T2DM patients.
Abstract:
Cardiovascular disease is the number one cause of death in patients with type 2 diabetes mellitus. This condition leads to an increased risk of premature mortality in patients with ischemic heart disease and stroke. Many risk factors besides hyperglycemia in itself contribute to this increased risk, acting in a synergistic fashion. One of the most important risk factors is hypertension. Several recent clinical trials have shown the benefits of reducing high blood pressure in patients with diabetes mellitus to lower levels than have previously been recommended in clinical guidelines. In both the United Kingdom Prospective Diabetes Study (UKPDS) and the Hypertension Optimal Treatment (HOT) study a significant trend for increased benefits associated with lower diastolic blood pressure levels was shown. Therefore, clinicians should be encouraged to do more to treat hypertension in patients with type 2 diabetes mellitus and increase the proportion of patients in whom acceptable blood pressure control is achieved. For example, in Sweden, acceptable blood pressure control is currently only achieved in about 20 to 25% of patients with type 2 diabetes mellitus. Recent evidence also points to the primary importance of a tight blood pressure control. This implies drug combination treatment for the majority of patients. Therefore, the clinician must be able to use a broad variety of antihypertensive drugs, and from these drugs choose alternative combinations with pharmacological synergism.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...